-
1h 1m 38s
-
1h 1m 4sPart 2 | Session 8 Plenary Session 11: Managing the HF patient with valvular heart disease
-
1h 1m 28sPart 2 | Session 10 Plenary Session 12: Managing the patient with worsening and advanced HF
-
1h 1m 14s
-
1h 22sPart 1 | Session 3 Plenary Session 2: Managing your HF patients with comorbidities (part 1)
-
1h 1m 19sPart 1 | Session 6 Plenary Session 3: Using SGLT2 in your patients: practical considerations
-
53m 32sPart 1 | Session 8 Plenary Session 4: Managing your HF patients with comorbidities (part 2)
-
1h 2m 37sPart 1 | Session 11 Plenary Session 5: Managing side effects of HF drugs
-
37m 5sPart 1 | Session 12 Meet the expert: Sex differences in advanced heart failure
-
1h 1m 4sPart 1 | Session 13 Plenary Session 6: How to manage the obese patient with HF
-
1h 2m 46sPart 2 | Session 1 Plenary Session 7: New technologies to manage your patients
-
1h 4m 11sPart 2 | Session 3 Plenary Session 8: New technologies to treat your patients
-
1h 9sPart 2 | Session 4 Plenary Session 9: Comparing European and US recent guidelines
e-SPACE Heart Failure 2022 was the third edition of the annual global online conference on heart failure. Bringing together thought-leaders from across the globe and broadcast over three time-zones – Asia, Europe, and the Americas – e-SPACE Heart Failure 2022 optimised geographical reach whilst delivering both global and regional insight.
Course leadership Prof Stefan Anker (Charité Campus Virchow-Klinikum, Berlin, DE), Dr Javed Butler (Baylor Scott and White Research Institute, Texas, US), Prof Andrew Coats (University of Warwick, Coventry, UK) and Dr Shelley Zieroth (University of Manitoba, Manitoba, CA) lead an interactive programme of plenary sessions, meet the experts, case discussions and industry sponsored sessions focusing on the patient journey.
For the first time, e-SPACE Heart Failure 2022 brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management in the regional contexts
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day 1
Part 2
Day 2
Faculty Biographies
John JV McMurray
Professor of Cardiology
Prof John McMurray is Professor of Medical Cardiology and Deputy Director of the Institute of Cardiovascular and Medical Sciences at the University of Glasgow, and honorary Consultant Cardiologist at the Queen Elizabeth University Hospital, Glasgow. A graduate of Manchester University, Prof McMurray completed postgraduate research at the University of Dundee.
Prof McMurray is a Fellow of the European Society of Cardiology (ESC), American College of Cardiology and American Heart Association as well as the medical Royal Colleges in Edinburgh and Glasgow and the Royal Society of Edinburgh and UK Academy of Medical Sciences.
Biykem Bozkurt
Dr Biykem Bozkurt is the Immediate Past President of the Heart Failure Society of America.
Dr Bozkurt is a Professor of Medicine, an advanced heart failure and cardiac transplantation specialist, Medical Care Line Executive (Medicine Department Chair) at the DeBakey VA Medical Center; W.A. “Tex” and Deborah Moncrief, Jr., Chair; Mary and Gordon Cain Chair; Vice-Chair of Department of Medicine; Director of the Winters Center for Heart Failure and Associate Director of Cardiovascular Research Institute at Baylor College of Medicine.
Giuseppe Rosano
Consultant Cardiologist and Professor of Cardiology (Hon)
Giuseppe Rosano was born and raised in Vibo Valentia, Italy, where he developed an early interest in medicine and cardiovascular science. While detailed information about his family and early childhood is not widely published, his Italian background and international academic career reflect strong cultural roots combined with global engagement in cardiovascular medicine.
Academic History
Professor Rosano obtained his Medical Degree in Medicine and Surgery with full honours from La Sapienza University of Rome in 1988. He subsequently completed his specialisation in Cardiology in 1992. Following his clinical training, he pursued advanced academic and research qualifications in the United Kingdom, earning both an MSc and a PhD in Medical Sciences from Imperial College London. His postgraduate research focused on cardiovascular physiology and pharmacology, forming the foundation of his future work in heart failure and cardiac metabolism.
Stephen J Greene
Assistant Professor, Division of Cardiology
Dr Greene is a cardiologist with a clinical and research interest in improving quality of care and outcomes for patients with heart failure. He has been a co-investigator and co-author of multiple national and international heart failure trials studying medical therapies for heart failure. He has also served on leadership committees and led multiple analyses from national and international heart failure registries characterising the quality of heart failure care. Dr Greene’s collaborative work has led to more than 350 publications in peer-reviewed journals.